Acute Isolated Thrombocytopenia Secondary to Meloxicam Use: A Case Report

Division

South Atlantic

Hospital

Grand Strand Medical Center

Document Type

Case Report

Publication Date

1-14-2022

Keywords

bleeding disorders, nsaids, isolated thrombocytopenia, drug-induced thrombocytopenia, meloxicam, drug-related side effects and adverse reactions

Disciplines

Hemic and Lymphatic Diseases | Internal Medicine

Abstract

Meloxicam is a widely used nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain and some inflammatory disorders. One rare side effect is drug-induced thrombocytopenia (DITP), which can result in hemorrhage and death if not treated urgently. This diagnosis can be missed if mistaken for other conditions such as ITP, which is problematic since the mainstay of treatment is medication cessation. We present a case of a 42-year-old Hispanic female who was recently started on meloxicam and presented with petechiae, ecchymosis, and a platelet count of 2 (normal 150-350 K/mm3).

Publisher or Conference

Cureus

Link to Full Text

Share

COinS